good company - Recensione dipendente - Formulation Scientist presso Oncorus

5,0
1 mag 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

this is a high pay

Svantaggi

this company no longer exists

Esplora altre recensioni su Oncorus

5,0
29 lug 2023
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great company, innovative cancer immunotherapy platform

Svantaggi

Suffered the fate of many biotech startups in a tough investment envirnoment

4,0
4 gen 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Collaboration between different departments for common goal

Svantaggi

Leadership didn’t always agree with each other

Vedi recensioni per: Utile|Valutazione|Data|Tutto